Vetter Inaugurates Ravensburg South Site

Vetter recently inaugurated its Ravensburg South site with a new 862,000 sq.-ft. area that now includes facilities for the aseptic filling and packaging of injectable drugs. The location features three buildings: a production facility, a final assembly and packaging plant, and a lab for ongoing production-related analyses. The company has invested approximately $220 million in the site and is investing another $73 million to expand pharmaceutical production.

The new location features maximum production automation, the use of RABS (Restricted Access Barrier Systems), central material supply with optimized material flows, and two independent filling lines. The two filling lines were the first segments of the expanded production site to begin operating in early 2007. Currently, final preparations are being made for a third production line, which is scheduled for completion by mid 2011.

The new Vetter Secondary Packaging (VSP) facility, in which the final assembly and packaging of the pre-filled injection systems is handled, is the last step of the company’s complete service offering. The entire VPS process, from hand-packaging and assembly of pens, auto-injectors and safety devices to the fully automated final packaging, takes place in the Ravensburg South plant. It has been operating fully since May 2009.

The final component of the Ravensburg Vetter South Laboratory (RVS-Lab) is the new lab, which includes a microbiological lab and chemical analysis area in new, specially designed spaces.